• 340B Mega Reg Moves Closer to Publication

    April 10, 2014 On April 9, the Office of Information and Regulatory Affairs (OIRA) posted that the 340B Omnibus Notice of Proposed Rulemaking (commonly referred to as the “mega-reg”) was currently under review by the Office of Management and Budget (OMB).  The period for OIRA review is limited by Executive Order 12866 to 90 days,… Read more »

  • HRSA 340B Program Registration

    HRSA- 340B Discounted Drug Pricing Program Open enrollment begins April 1 and runs through the 15th .  All new entities and new contract pharmacy arrangements should be finalized before the deadline of midnight April 15. For further information  call Mary Ellen England -954-602-5166

  • HRSA Describes Proposed 340B User Fee

    In its annual budget justification to Congress, HRSA provided a summary of attributes of a possible 340B User fee. Purpose: The user fee provides the resources needed to improve program integrity and implement statutory provisions while reducing the government expenditure of taxpayer dollars. It will also help address recommendations by the Office of Inspector General… Read more »

  • CMS orders insurers to accept Ryan White premium assistance

      Modern Healthcare By Joe Carlson Posted: March 14, 2014 – 6:15 pm ET The CMS ordered all insurance companies selling plans through insurance exchanges to accept premium payments and co-payment assistance from federal programs like the Ryan White HIV/AIDS program. But the government continued to urge insurers to reject premium assistance provided by hospitals, drug companies and devicemakers. Full… Read more »

  • White House reverses $10B in cuts to ACA cost-sharing subsidies

    By Paul Demko Posted: March 13, 2014 – 6:30 pm ET  Modern HealthCare Tags: Costs, Healthcare Reform, Insurance Exchanges, Insurance, Medicare   The White House has decided to reverse roughly $10 billion in cuts to the cost-sharing subsidies that were part of the Patient Protection and Affordable Care Act. That program was originally expected to be slashed by 7.3 % in… Read more »

  • HHS-OIG Criticizes 340B Drug Discount Program

    Posted By Theresa C. Carnegie on February 11th, 2014Posted in Hospitals & Health Systems, Payors & PBMs, Pharma & Medical Devices, Pharmacies, State & Federal Audits, Investigations & Litigation Written by:  Ellyn L. Sternfield I recently posted that 2014 is expected to be a year of major developments in the 340B Drug Discount Program, with HRSA receiving enhanced funding, stepping up audit activity, and drafting regulations in response to… Read more »

  • Is 2014 a Game Changer for the 340B Drug Discount Program

    As reported in Health Law and Policy Matters January 31, 2014 (1/29, Ellyn L. Sternfield, Health Law & Policy Matters) reports “…The year 2014 looks to be a year of major developments for the 340B Drug Discount Program. We have seen (1) a first in terms of the Health Resources and Services Administration (HRSA) imposing… Read more »

  • 340B Recertification for HRSA and IHS Grantees Underway

    The Health Resources and Services Administration (HRSA) and Office of Pharmacy Affairs (OPA) has announced that re-certification for Tribal and Urban Indian entities, HRSA grantees, and CDC STD/TB grantees is scheduled to begin on February 10, 2014. The deadline for the completion of the re-certification process will be March 14, 2014. Each covered entity’s Authorizing… Read more »

  • RxStrategies sponsors -340B Coalition Fun Run

    RxStrategies, Inc  has sponsored the First Annual 5 K Fun Run/Walk for the benefit of PATH a family of agencies working to end homelessness for individuals, families and communities throughout Southern California.  Join us February 7 from 7:00 am – 8:00 am along the beautiful beach out front of the Hotel Del Coronado.  All participants… Read more »